project id: TCGA-LIHC; case submitter id: TCGA-2V-A95S; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.33; rna integrity number: 7.5; ethnicity: not hispanic or latino; gender: male; race: asian; vital status: Alive; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; icd 10 code: C22.0; last known disease status: not reported; morphology: 8170/3; primary diagnosis: Hepatocellular carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Liver; synchronous malignancy: No; tissue or organ of origin: Liver; tumor grade: Not Reported; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 170.0; portion submitter id: TCGA-2V-A95S-01A-11; percent lymphocyte infiltration: 90.0; percent monocyte infiltration: 10.0; percent necrosis: 20.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 50.0; percent tumor nuclei: 70.0;